D. Crowther

A predictive model for aggressive non-Hodgkin's lymphoma

Margaret A. Shipp, David P. Harrington, J R Anderson et al. · 1993 · 3.5K citations

Medicine, Oncology, Chemotherapy +15

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Tim Lister, D. Crowther, S.B. Sutcliffe et al. · Journal of Clinical Oncology · 1989 · 1.6K citations

Medicine, Oncology, Radiology +14

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

MH Bronchud, J.H. Scarffe, Nicholas Thatcher et al. · British Journal of Cancer · 1987 · 597 citations · Full text

Medicine, Hematology, Oncology +15

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis et al. · Journal of Clinical Oncology · 1999 · 570 citations

Medicine, Oncology, Pharmacology +16

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Ruth Pettengell, Howard Gurney, DP Deakin et al. · Blood · 1992 · 411 citations · Full text

Medicine, Hematology, Oncology +12